These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 25332117)

  • 1. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
    Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
    Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
    McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
    Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
    Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
    J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
    Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
    Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Williams CD; Gajra A; Ganti AK; Kelley MJ
    Cancer; 2014 Jul; 120(13):1939-47. PubMed ID: 24668613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
    J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.
    Aspinall SL; Good CB; Zhao X; Cunningham FE; Heron BB; Geraci M; Passero V; Stone RA; Smith KJ; Rogers R; Shields J; Sartore M; Boyle DP; Giberti S; Szymanski J; Smith D; Ha A; Sessions J; Depcinski S; Fishco S; Molina I; Lepir T; Jean C; Cruz-Diaz L; Motta J; Calderon-Vargas R; Maland J; Keefe S; Tague M; Leone A; Glovack B; Kaplan B; Cosgriff S; Kaster L; Tonnu-Mihara I; Nguyen K; Carmichael J; Clifford L; Lu K; Chatta G
    BMC Cancer; 2015 Feb; 15():62. PubMed ID: 25884851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes.
    Vergidis J; Gresham G; Lim HJ; Renouf DJ; Kennecke HF; Ruan JY; Chang JT; Cheung WY
    Clin Colorectal Cancer; 2016 Mar; 15(1):16-23. PubMed ID: 26281943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.